Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aidigong Maternal & Child Health ( (HK:0286) ) just unveiled an announcement.
Aidigong Maternal & Child Health said its group operations have continued uninterrupted even as trading in its Hong Kong-listed shares remains suspended, and it is still working to finalize financial information from key subsidiary Shenzhen Aidigong for the audit of its 2024 annual results and report. The company acknowledged delays due to difficulties in obtaining documents needed for an independent forensic investigation and internal control review, and it is working with advisers on a comprehensive resumption proposal while also reviewing its board composition to satisfy Hong Kong listing rule requirements, pledging to keep shareholders and potential investors updated on progress toward trading resumption.
More about Aidigong Maternal & Child Health
Aidigong Maternal & Child Health Limited is a Bermuda-incorporated company listed in Hong Kong that operates maternal and child health services through its subsidiaries. The group’s business continues to run despite a prolonged suspension of trading in its shares on the Hong Kong Stock Exchange, reflecting its focus on maintaining core operations while addressing regulatory issues.
Technical Sentiment Signal: Sell
Current Market Cap: HK$251.6M
For detailed information about 0286 stock, go to TipRanks’ Stock Analysis page.